Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Cutaneous side-effects of EGFR inhibitors and their management Ehmann LM; Ruzicka T; Wollenberg ASkin Therapy Lett 2011[Jan]; 16 (1): 1-3Epidermal growth factor receptor (EGFR) inhibitors are an increasingly important treatment option for metastasized cancer in patients. In addition to the pivotal role of EGFR in the development and progression of malignant tumors, EGFR is also important for proliferation and differentiation of the human epidermis and hair follicles. As a consequence, cutaneous side-effects are frequently observed during cancer therapy with EGFR inhibitors. During the first few weeks of treatment, acneiform eruptions are the earliest common side-effect. Xerosis and fissures are complications appearing in later treatment phases. Paronychia and alterations in hair growth are less common and generally seen after a longer period of treatment. We present an overview of the various cutaneous side-effects associated with EGFR inhibition and discuss their respective therapeutic options.|Acneiform Eruptions/*chemically induced/drug therapy[MESH]|Administration, Oral[MESH]|Adrenal Cortex Hormones/therapeutic use[MESH]|Anti-Infective Agents, Local/therapeutic use[MESH]|Cephalosporins/therapeutic use[MESH]|ErbB Receptors/*antagonists & inhibitors[MESH]|Fluoroquinolones/therapeutic use[MESH]|Humans[MESH]|Hyperpigmentation/chemically induced[MESH]|Neoplasms/drug therapy[MESH]|Paronychia/*chemically induced/drug therapy[MESH]|Protein Kinase Inhibitors/*adverse effects/therapeutic use[MESH]|Retinoids/therapeutic use[MESH]|Telangiectasis/chemically induced[MESH] |